(Q34105601)

31 July 2017

1 reference

title

Cytokines involved in Toxoplasmic encephalitis (English)

1 reference

31 July 2017

1 reference

Sarciron ME

1

1 reference

31 July 2017

Gherardi A

series ordinal

2

1 reference

31 July 2017

publication date

1 December 2000

1 reference

Scandinavian Journal of Immunology

31 July 2017

published in

1 reference

31 July 2017

volume

52

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

534-543

1 reference

The role of cytokines in toxoplasmosis

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

Toxoplasma gondii: an AIDS enhancing cofactor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

The diagnosis of toxoplasmosis using IgG avidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

Rapid change in the use of antiretroviral agents and improvement in a population of HIV-infected patients: France, 1995-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies. Tuscany AIDS Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

Estimating AIDS-free survival in a severely immunosuppressed asymptomatic HIV-infected population in the era of antiretroviral triple combination therapy. Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

Anti-human immunodeficiency virus drug combination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

Toxoplasma gondii: blood and tissue kinetics during acute and chronic infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

Cytokines, Toxoplasma and intracellular parasitism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

Detection of cytokine mRNA in the brains of mice with toxoplasmic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

A protective role for IL-6 during early infection with Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

Functional dichotomy of mouse microglia developed in vitro: differential effects of macrophage and granulocyte/macrophage colony-stimulating factor on cytokine secretion and antitoxoplasmic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

Influence of cytokines on Toxoplasma gondii growth in human astrocytoma-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

Role of IFN-gamma, TNF-alpha, IL4 and IL10 in the regulation of experimental Toxoplasma gondii infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

Interleukin-10 downregulates the intracerebral immune response in chronic Toxoplasma encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

Elevated interleukin-10-to-interleukin-12 ratio in feline immunodeficiency virus-infected cats predicts loss of type 1 immunity to Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

Anti-parasitic effector mechanisms in human brain tumor cells: role of interferon-gamma and tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

Immunization with heat-killed Toxoplasma gondii stimulates an early IFN-gamma response and induces protection against virulent murine malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

Biological properties of interleukin 10

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2000.00817.X

10.1046/J.1365-3083.2000.00817.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference